Investor Relations

Our mission is simple—help patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop a safe and clinically backed treatment. Bringing new treatments to market will help improve patients' treatment options and lives.

Investor Relations

Copyright Nasdaq. Minimum 15 minutes delayed.

News Releases
August 13, 2018
electroCore, Inc. Announces Second Quarter Financial Results

BASKING RIDGE, N.J. , Aug. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three month and six months ended June 30, 2018 . Second Quarter 2018 and Recent Highlights Second

Investor Contact

Investor Relations

Lynn Pieper Lewis
investors@electrocore.com